Free Trial

BriaCell Therapeutics (BCT) Competitors

→ Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad)
Free BCT Stock Alerts
C$2.29
+0.15 (+7.01%)
(As of 05/31/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarnings

BCT vs. IPA, SVA, ONC, SCYB, COM, NVH, IGX, TH, PDP, and COV

Should you be buying BriaCell Therapeutics stock or one of its competitors? The main competitors of BriaCell Therapeutics include ImmunoPrecise Antibodies (IPA), Sernova (SVA), Oncolytics Biotech (ONC), Scythian Biosciences (SCYB), 138267 (COM.TO) (COM), Novoheart (NVH), IntelGenx Technologies (IGX), Theratechnologies (TH), Pediapharm (PDP), and Covalon Technologies (COV). These companies are all part of the "biotechnology" industry.

BriaCell Therapeutics vs.

ImmunoPrecise Antibodies (CVE:IPA) and BriaCell Therapeutics (TSE:BCT) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their community ranking, institutional ownership, analyst recommendations, earnings, valuation, profitability, risk, dividends and media sentiment.

In the previous week, BriaCell Therapeutics' average media sentiment score of 0.00 equaled ImmunoPrecise Antibodies'average media sentiment score.

Company Overall Sentiment
ImmunoPrecise Antibodies Neutral
BriaCell Therapeutics Neutral

BriaCell Therapeutics has lower revenue, but higher earnings than ImmunoPrecise Antibodies. ImmunoPrecise Antibodies is trading at a lower price-to-earnings ratio than BriaCell Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ImmunoPrecise AntibodiesC$19.47M8.33-C$22.19M-C$0.89-7.30
BriaCell TherapeuticsN/AN/A-C$12.61M-C$1.07-2.14

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ImmunoPrecise Antibodies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
BriaCell Therapeutics
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

ImmunoPrecise Antibodies received 39 more outperform votes than BriaCell Therapeutics when rated by MarketBeat users. However, 100.00% of users gave BriaCell Therapeutics an outperform vote while only 54.79% of users gave ImmunoPrecise Antibodies an outperform vote.

CompanyUnderperformOutperform
ImmunoPrecise AntibodiesOutperform Votes
40
54.79%
Underperform Votes
33
45.21%
BriaCell TherapeuticsOutperform Votes
1
100.00%
Underperform Votes
No Votes

BriaCell Therapeutics' return on equity of 0.00% beat ImmunoPrecise Antibodies' return on equity.

Company Net Margins Return on Equity Return on Assets
ImmunoPrecise AntibodiesN/A N/A N/A
BriaCell Therapeutics N/A -206.01%-85.45%

12.0% of BriaCell Therapeutics shares are owned by institutional investors. 10.7% of BriaCell Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

BriaCell Therapeutics beats ImmunoPrecise Antibodies on 6 of the 11 factors compared between the two stocks.

Get BriaCell Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BCT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BCT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

BCT vs. The Competition

Export to Excel
MetricBriaCell TherapeuticsBiotechnology IndustryMedical SectorTSE Exchange
Market CapC$41.86MC$138.95MC$5.17BC$5.46B
Dividend Yield13.70%3.49%2.76%5.58%
P/E Ratio-2.14201.85113.7820.83
Price / SalesN/A19,266.742,386.072,548.93
Price / CashN/A11.5335.4179.75
Price / Book-4.587.225.543.54
Net Income-C$12.61M-C$20.82MC$106.07MC$287.78M
7 Day Performance16.24%1.26%1.14%-0.16%
1 Month Performance-24.92%4.46%0.65%2.59%
1 Year PerformanceN/A5.92%2.69%29.08%

BriaCell Therapeutics Competitors List

Export to Excel
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IPA
ImmunoPrecise Antibodies
0 of 5 stars		C$6.50
+0.8%		N/A+0.0%C$162.08MC$19.47M-7.3073Gap Down
SVA
Sernova
1.0779 of 5 stars		C$0.37
+12.1%		C$1.50
+305.4%		-54.9%C$112.26MN/A-2.851,959Gap Down
ONC
Oncolytics Biotech
0.4274 of 5 stars		C$1.46
-0.7%		C$3.00
+105.5%		-34.8%C$110.11MN/A-3.6529
SCYB
Scythian Biosciences
0 of 5 stars		C$3.49
-5.9%		N/A+0.0%C$102.38MN/A0.00N/AHigh Trading Volume
COM
138267 (COM.TO)
0 of 5 stars		N/AN/AN/AC$102.19MN/A0.00N/A
NVH
Novoheart
0 of 5 stars		C$0.53
+1.9%		N/A+0.0%C$99.98MC$423,500.00-13.95N/A
IGX
IntelGenx Technologies
0 of 5 stars		C$0.58
+1.8%		N/A+0.0%C$87.32MC$1.75M-7.4448Gap Up
TH
Theratechnologies
0.8535 of 5 stars		C$1.71
-1.2%		C$5.50
+221.6%		+47.4%C$78.63MC$78.10M-2.16103
PDP
Pediapharm
0 of 5 stars		C$0.30
+1.7%		N/A+0.0%C$66.36MC$11.16M-4.11N/A
COV
Covalon Technologies
0 of 5 stars		C$2.18
+4.3%		N/A+14.7%C$53.78MC$25.07M-11.47N/ANews Coverage
Gap Up
High Trading Volume

Related Companies and Tools

Related Companies:
Top 10 Stock Comparisons
This page (TSE:BCT) was last updated on 6/2/2024 by MarketBeat.com Staff

From Our Partners
Trump’s Gift Could Unleash $51 Billion in New Wealth
Wealthpin Pro
Dems have chosen Biden replacement?
Paradigm Press
Biden Nomination CANCELED?
The Freeport Society
Buy this small stock before coming AI Tidal Wave
Chaikin Analytics
Warren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…
InvestorPlace
Exposed: 10 CENT Crypto to Explode May 20th?
True Market Insiders
He Is Giving Away Bitcoin
Crypto Swap Profits
Write this ticker symbol down…
StocksToTrade